관류 시스템 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 지역별, 부문별 예측(2024-2030년)

Perfusion Systems Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Perfusion System, Cell Perfusion System), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,152,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,522,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,262,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

관류 시스템 시장 성장 및 동향:

Grand View Research의 최신 보고서에 따르면, 세계 관류 시스템 시장 규모는 2030년까지 15억 5,000만 달러에 달할 것으로 예상됩니다.

또한, 이 시장은 2024년부터 2030년까지 연평균 4.8%의 성장률을 기록할 것으로 예상됩니다. 만성 질환의 유병률 증가, 장기 이식 및 다발성 장기 부전 증가 등의 요인이 시장 성장을 촉진할 것으로 예상됩니다. 또한, 세포 기반 연구에 대한 투자 증가와 생물학적 제제 제조 증가는 관류 시스템 산업의 성장을 더욱 촉진할 것으로 예상됩니다.

대유행 전반기에 관류 시스템 판매량이 급감했습니다. 세계 각국 정부의 봉쇄와 규제로 인해 병원을 찾는 환자가 감소하고, 수술 건수가 감소하고, 연구 개발 활동이 둔화되었습니다. 그러나 바이러스 확산을 억제하고 향후 유사한 사태에 대비하기 위한 정부와 의료진의 노력이 강화됨에 따라 2021년에는 시장이 회복세로 돌아서고 예측 기간 동안 번창할 것으로 예상됩니다.

관류 시스템 시장 보고서 하이라이트

• 관류 시스템 시장은 용도에 따라 심폐 관류 시스템, 세포 관류 시스템, 생체 외 장기 관류 시스템으로 구분됩니다. 전 세계적으로 심장 질환의 높은 유병률로 인해 2023년에는 심폐 관류 시스템이 시장을 주도했습니다.
• 지역별로는 북미가 2023년 가장 높은 시장 점유율을 차지했습니다. 만성 질환 유병률 증가, 잘 확립된 의료 부문, 장기 기증자 수 증가가 이 지역의 시장 성장을 주도하고 있습니다.
• COVID-19 팬데믹은 관류 시스템 시장에 큰 부정적인 영향을 미쳤습니다. 의료 우선순위의 변화, 사회적 거리두기, 전 세계 봉쇄 등의 요인으로 인해 수술 건수가 감소하고 장기 기증 및 이식 건수도 감소했습니다.
• 코로나 바이러스 전염병은 관류 시스템 판매 감소로 이어졌지만, 전염병의 첫 번째 물결이 사라진 후 시장은 회복되어 예측 기간 동안 COVID 이전 성장 수준에 도달할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 관류 시스템 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 관류 시스템 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 관류 시스템 시장 : 용도별 추정·동향 분석

• 부문 대시보드
• 관류 시스템 시장 : 용도별 변동 분석
• 관류 시스템 시장 용도별 전망
• 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
• 심폐 관류 시스템
• 세포 관류 시스템
• 체외 장기 관류 시스템

제5장 관류 시스템 시장 : 지역별 추정·동향 분석

• 지역 대시보드
• 관류 시스템 시장 : 지역별 변동 분석
• 관류 시스템 시장 : 기술과 최종 용도별 지역 추정·동향 분석
• 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
• 북미
  • 북미의 관류 시스템 시장 추정과 예측, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 관류 시스템 시장 추정과 예측, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양의 관류 시스템 시장 추정과 예측, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 라틴아메리카의 관류 시스템 시장 추정과 예측, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 관류 시스템 시장 추정과 예측, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제6장 경쟁 상황

• 시장 진출 기업 분류
• 주요 기업 개요
  • Getinge
  • Medtronic, plc
  • LivaNova PLC
  • Terumo Corporation
  • Nipro Corporation
  • Fresenius SE &Co. KGaA(XENIOS AG)
  • Repligen Corporation
  • Spectrum Medical
  • Merck KGaA
  • Harvard Bioscience, Inc.
  • Lifeline Scientific
  • ALA Scientific Instruments, Inc.
  • XVIVO Perfusion AB

ksm

영문 목차

영문목차

Perfusion Systems Market Growth & Trends:

The global perfusion systems market size is projected to reach USD 1.55 billion by 2030, according to a new report by Grand View Research, Inc. Furthermore, the market is projected to advance at a CAGR of 4.8% from 2024 to 2030. Factors such as the growing prevalence of chronic diseases and the rise in the number of organ transplants and multiple organ failures are anticipated to boost the market growth. In addition, increasing investments in cell-based research and a rise in biologics manufacturing are further expected to impel the growth of the perfusion system industry.

There was a steep downfall in the sales of perfusion systems during the first half of the pandemic. The lockdowns and restrictions imposed by governments globally resulted in reduced patient visits to hospitals, a reduced number of surgeries, and a slowdown in R&D activities. However, with the increasing efforts of the government and healthcare professionals to curb the spread of the virus and prepare for similar events in the future, the market began to recover in 2021 and is expected to flourish during the forecast period.

Perfusion Systems Market Report Highlights:

• Based on application, the perfusion systems market is segmented into cardiopulmonary perfusion system, cell perfusion system, and ex-vivo organ perfusion system. The cardiopulmonary perfusion system dominated the market in 2023 due to the high prevalence of cardiac diseases globally
• In terms of region, North America accounted for the highest market share in 2023. The rising incidences of chronic disorders, a well-established healthcare sector, and a rise in the number of organ donors are driving the regional market growth
• The COVID-19 pandemic had a significant negative impact on the market for perfusion systems. Factors such as the change in healthcare priorities, social distancing, and global lockdowns resulted in a reduced number of surgeries and a fall in the number of organ donations and transplants
• The coronavirus outbreak led to a decline in the sales of perfusion systems; however, post the first wave of the pandemic, the market recovered and is expected to reach its pre-COVID growth level during the forecast period

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1 Segment Definitions
  • 1.1.2. Application
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Perfusion Systems Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of cardiovascular and respiratory diseases
    • 3.2.1.2. Rising number of organ transplantations
    • 3.2.1.3. Growth in aging population and increasing incidence of multiple organ failures
    • 3.2.1.4. Government and NGO initiatives to encourage organ donation
    • 3.2.1.5. Increasing investments in cell-based research
    • 3.2.1.6. Rise in biologic manufacturing
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of organ transplantation
    • 3.2.2.2. Ethical concerns and high cost of cell-based research
• 3.3. Perfusion Systems Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Perfusion systems Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Perfusion Systems Market: Application Movement Analysis
• 4.3. Perfusion Systems Market by Application Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Cardiopulmonary Perfusion System
  • 4.5.1. Cardiopulmonary Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Oxygenators
    • 4.5.2.1. Oxygenators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Heart-Lung Machine
    • 4.5.3.1. Heart-Lung Machine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Perfusion Pumps
    • 4.5.4.1. Perfusion Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.5. Cannula
    • 4.5.5.1. Cannula Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.6. Monitoring System
    • 4.5.6.1. Monitoring System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.7. Others
    • 4.5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Cell Perfusion System
  • 4.6.1. Cell Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Bioreactor Perfusion System
    • 4.6.2.1. Bioreactor Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Microfluidic Perfusion System
    • 4.6.3.1. Microfluidic Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.4. Gravity/Pressure-driven Perfusion System
    • 4.6.4.1. Gravity/Pressure-driven Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.5. Small Mammal Organ Perfusion System
    • 4.6.5.1. Small Mammal Organ Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Ex-Vivo Organ Perfusion System
  • 4.7.1. Ex-Vivo Organ Perfusion System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7.2. Hypothermic
    • 4.7.2.1. Hypothermic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7.3. Normothermic
    • 4.7.3.1. Normothermic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Perfusion Systems Market: Regional Estimates & Trend Analysis

• 5.1. Regional Dashboard
• 5.2. Regional Perfusion systems Market movement analysis
• 5.3. Perfusion systems Market: Regional Estimates & Trend Analysis by Technology & End-use
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. North America
  • 5.5.1. North America Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. U.S.
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Competitive Scenario
    • 5.5.2.3. Regulatory Framework
    • 5.5.2.4. Reimbursement scenario
    • 5.5.2.5. U.S. Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Canada
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Competitive Scenario
    • 5.5.3.3. Regulatory Framework
    • 5.5.3.4. Reimbursement scenario
    • 5.5.3.5. Canada Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. Mexico
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Competitive Scenario
    • 5.5.4.3. Regulatory Framework
    • 5.5.4.4. Reimbursement scenario
    • 5.5.4.5. Mexico Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Europe
  • 5.6.1. Europe Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. UK
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Competitive Scenario
    • 5.6.2.3. Regulatory Framework
    • 5.6.2.4. Reimbursement scenario
    • 5.6.2.5. UK Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. Germany
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Competitive Scenario
    • 5.6.3.3. Regulatory Framework
    • 5.6.3.4. Reimbursement scenario
    • 5.6.3.5. Germany Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.4. France
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Competitive Scenario
    • 5.6.4.3. Regulatory Framework
    • 5.6.4.4. Reimbursement scenario
    • 5.6.4.5. France Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.5. Italy
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Competitive Scenario
    • 5.6.5.3. Regulatory Framework
    • 5.6.5.4. Reimbursement scenario
    • 5.6.5.5. Italy Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.6. Spain
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Competitive Scenario
    • 5.6.6.3. Regulatory Framework
    • 5.6.6.4. Reimbursement scenario
    • 5.6.6.5. Spain Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.7. Denmark
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Competitive Scenario
    • 5.6.7.3. Regulatory Framework
    • 5.6.7.4. Reimbursement scenario
    • 5.6.7.5. Denmark Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.8. Sweden
    • 5.6.8.1. Key Country Dynamics
    • 5.6.8.2. Competitive Scenario
    • 5.6.8.3. Regulatory Framework
    • 5.6.8.4. Reimbursement scenario
    • 5.6.8.5. Sweden Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.9. Norway
    • 5.6.9.1. Key Country Dynamics
    • 5.6.9.2. Competitive Scenario
    • 5.6.9.3. Regulatory Framework
    • 5.6.9.4. Reimbursement scenario
    • 5.6.9.5. Norway Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Asia Pacific
  • 5.7.1. Asia Pacific Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.2. Japan
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Competitive Scenario
    • 5.7.2.3. Regulatory Framework
    • 5.7.2.4. Reimbursement scenario
    • 5.7.2.5. Japan Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.3. China
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Competitive Scenario
    • 5.7.3.3. Regulatory Framework
    • 5.7.3.4. Reimbursement scenario
    • 5.7.3.5. China Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.4. India
    • 5.7.4.1. Key Country Dynamics
    • 5.7.4.2. Competitive Scenario
    • 5.7.4.3. Regulatory Framework
    • 5.7.4.4. Reimbursement scenario
    • 5.7.4.5. India Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.5. South Korea
    • 5.7.5.1. Key Country Dynamics
    • 5.7.5.2. Competitive Scenario
    • 5.7.5.3. Regulatory Framework
    • 5.7.5.4. Reimbursement scenario
    • 5.7.5.5. South Korea Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.6. Australia
    • 5.7.6.1. Key Country Dynamics
    • 5.7.6.2. Competitive Scenario
    • 5.7.6.3. Regulatory Framework
    • 5.7.6.4. Reimbursement scenario
    • 5.7.6.5. Australia Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.7. Thailand
    • 5.7.7.1. Key Country Dynamics
    • 5.7.7.2. Competitive Scenario
    • 5.7.7.3. Regulatory Framework
    • 5.7.7.4. Reimbursement scenario
    • 5.7.7.5. Thailand Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Latin America
  • 5.8.1. Latin America Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.2. Brazil
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Competitive Scenario
    • 5.8.2.3. Regulatory Framework
    • 5.8.2.4. Reimbursement scenario
    • 5.8.2.5. Brazil Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.3. Argentina
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Competitive Scenario
    • 5.8.3.3. Regulatory Framework
    • 5.8.3.4. Reimbursement scenario
    • 5.8.3.5. Argentina Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Middle East & Africa
  • 5.9.1. Middle East & Africa Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9.2. South Africa
    • 5.9.2.1. Key Country Dynamics
    • 5.9.2.2. Competitive Scenario
    • 5.9.2.3. Regulatory Framework
    • 5.9.2.4. Reimbursement scenario
    • 5.9.2.5. South Africa Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9.3. Saudi Arabia
    • 5.9.3.1. Key Country Dynamics
    • 5.9.3.2. Competitive Scenario
    • 5.9.3.3. Regulatory Framework
    • 5.9.3.4. Reimbursement scenario
    • 5.9.3.5. Saudi Arabia Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9.4. UAE
    • 5.9.4.1. Key Country Dynamics
    • 5.9.4.2. Competitive Scenario
    • 5.9.4.3. Regulatory Framework
    • 5.9.4.4. Reimbursement scenario
    • 5.9.4.5. UAE Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9.5. Kuwait
    • 5.9.5.1. Key Country Dynamics
    • 5.9.5.2. Competitive Scenario
    • 5.9.5.3. Regulatory Framework
    • 5.9.5.4. Reimbursement scenario
    • 5.9.5.5. Kuwait Perfusion Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
• 6.2. Key Company Profiles
  • 6.2.1. Getinge
    • 6.2.1.1. Company overview
    • 6.2.1.2. Financial performance
    • 6.2.1.3. Product benchmarking
    • 6.2.1.4. Strategic initiatives
  • 6.2.2. Medtronic, plc
    • 6.2.2.1. Company overview
    • 6.2.2.2. Financial performance
    • 6.2.2.3. Product benchmarking
    • 6.2.2.4. Strategic initiatives
  • 6.2.3. LivaNova PLC
    • 6.2.3.1. Company overview
    • 6.2.3.2. Financial performance
    • 6.2.3.3. Product benchmarking
    • 6.2.3.4. Strategic initiatives
  • 6.2.4. Terumo Corporation
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. Nipro Corporation
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. Fresenius SE & Co. KGaA (XENIOS AG)
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. Repligen Corporation
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. Spectrum Medical
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives
  • 6.2.9. Merck KGaA
    • 6.2.9.1. Company overview
    • 6.2.9.2. Financial performance
    • 6.2.9.3. Product benchmarking
    • 6.2.9.4. Strategic initiatives
  • 6.2.10. Harvard Bioscience, Inc.
    • 6.2.10.1. Company overview
    • 6.2.10.2. Financial performance
    • 6.2.10.3. Product benchmarking
    • 6.2.10.4. Strategic initiatives
  • 6.2.11. Lifeline Scientific
    • 6.2.11.1. Company overview
    • 6.2.11.2. Financial performance
    • 6.2.11.3. Product benchmarking
    • 6.2.11.4. Strategic initiatives
  • 6.2.12. ALA Scientific Instruments, Inc.
    • 6.2.12.1. Company overview
    • 6.2.12.2. Financial performance
    • 6.2.12.3. Product benchmarking
    • 6.2.12.4. Strategic initiatives
  • 6.2.13. XVIVO Perfusion AB
    • 6.2.13.1. Company overview
    • 6.2.13.2. Financial performance
    • 6.2.13.3. Product benchmarking
    • 6.2.13.4. Strategic initiatives

관련자료